Month: August 2021

Company also joins 15 other industry-leading third-party data providers as part of Truthset Data Provider Network NEW YORK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Fluent, Inc. (NASDAQ: FLNT), a leading data-driven, performance marketing company, announced rankings in Truthset’s Truthscore™ Index for Q2 2021. Truthset is a data intelligence company, focused exclusively on validating the accuracy and compliance of consumer data. The Truthscore™ Index is a record-level rating measure of a single provider’s overall data quality within a given attribute segment relative to the entire cohort of data providers for the same segment. A data provider’s average Truthscore™ quantifies the probability that record-level consumer data is accurate across 20+ different attributes. In the first quarter of participation, Fluent scored highly on several...

SANTA MONICA, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) — GoodRx (NASDAQ: GDRX), America’s leading resource for healthcare savings, today announced that it has entered into an agreement with Surescripts, the nation’s leading health information network, to deliver drug discount price information to prescribers using Surescripts Real-Time Prescription Benefit when prescribing medications for uninsured patients and patients whose price information isn’t already available from their PBM or health plan. Surescripts Real-Time Prescription Benefit delivers cost information in the electronic workflow so prescribers can make more informed decisions and address patient prescription cost concerns at the point of care. Approximately one-third of Americans say they have skipped filling a prescription for a chronic condition one or more times because...

SAN CARLOS, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, today announced that its board of directors has authorized a $2 billion expansion of the company’s on-going share repurchase program. Under the extended share repurchase program, Check Point is authorized to continue repurchasing its shares up to $325 million each quarter. As of June 30, 2021, Check Point has approximately 133 million ordinary shares outstanding. Since the beginning of the share repurchase program, Check Point has repurchased approximately 188 million shares for a total purchase price of approximately $11.1 billion. The updated plan extends the company’s existing repurchase program from February 2020 which is expected to be completed during the fourth...

Spikes CBDX Launches Multiple Delta 8 Gummies Longwood, FL, Aug. 05, 2021 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of hemp and cannabinoid-infused beverages, along with an array of CBD topicals and tinctures, announces the launch of two flavors of Spikes CBDX Delta 8 Gummies. The Company announced the launch of its Delta 8 products to the Spikes CBDX lineup last week, and as Delta 8 has never been more popular than it is today, the Company is tapping into a fast-growing market. Product options are expanding in the market, and gummies seem to be a consumer favorite. To start, Spikes CBDX will be launching Delta 8 Gummies in two flavors: Blue Raspberry and Strawberry. As demand for Delta 8 continues to boom, the Company anticipates large growth in sales coming...

Ørsted will release its results for the first half-year of 2021 on Thursday 12 August 2021. The results will be released at approx. 8:00 CEST. In connection with the presentation of the interim financial report, an earnings call for investors and analysts will be held on the same day at 14:00 CEST. Dial in numbers for the earnings call:Denmark: +45 78 15 01 09UK: +44 333 300 9268USA: +1 833 823 0590 The earnings call can be followed live at:https://edge.media-server.com/mmc/p/vps2auvq   Presentation slides will be available prior to the earnings call at:www.orsted.com/en/investors/ir-material/financial-reports-and-presentations#0 For further information, please contact: Media RelationsCarsten Birkeland Kjær+ 45 99 55 77 65cabkj@orsted.dk Investor RelationsAllan Bødskov Andersen+ 45 99 55 79 96ir@orsted.dk About ØrstedThe Ørsted vision...

VANCOUVER, British Columbia, Aug. 05, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has shipped its initial order of edible cannabis gummies via its distribution partner to the British Columbia Liquor Distribution Branch (LDB). Demand for the Company’s Pure Chews branded THC and CBD gummies is strong within the provincial markets. All the Company’s SKUs including the 10 mg THC packs of Fire Burst, Strawberry and Mango utilize a proprietary manufacturing system licensed from US based Taste-T, LLC, the manufacturer of the successful Fireball Cinnamon gummies,...

Cepton Technologies, Inc. (“Cepton”), an innovator in light detection and ranging (lidar) for automotive Advanced Driver Assistance Systems (ADAS) and vehicle autonomy, to combine with Growth Capital Acquisition Corp. (“Growth Capital”, Nasdaq: GCAC) Business combination follows Cepton securing the ADAS industry’s largest lidar series production award1 from a leading global Top 5 automotive OEM‡, with expected start of deployment in consumer vehicles in 2023 With ongoing engagements with all of the Top 10 global automotive OEMs‡, Cepton is expected to be the first lidar company to penetrate the passenger vehicle mass market across multiple vehicle classes and models in the next several years, thereby enabling lidar to become an essential safety sensor The transaction values Cepton at an enterprise value of approximately $1.5 billion on...

Net Earnings of $377.3 million and $560.5 million for the Three and Six Months Ended June 30, 2021 Non-GAAP Operating Income1 of $290.5 million and $574.3 million for the Three and Six Months Ended June 30, 2021 Fully diluted book value per share of $304.59 as of June 30, 2021, an increase of 43.0% year over year After giving effect to strategic share repurchases completed subsequent to June 30, 2021, pro forma fully diluted book value per share2 of $319.25HAMILTON, Bermuda, Aug. 05, 2021 (GLOBE NEWSWIRE) — Enstar Group Limited (Nasdaq: ESGR) filed its quarterly report on Form 10-Q with the SEC earlier today, reporting its earnings and financial position for the three and six months ended June 30, 2021. Enstar reported consolidated net earnings of $377.3 million (or $17.28 per fully diluted ordinary share) and $560.5 million...

London, UK, Aug. 05, 2021 (GLOBE NEWSWIRE) — Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces its LinkResPet and DailyLifeCBD products will be available for purchase at Collins Tobacco & Vape Store 6750 Collins Miami Beach, a new stockist in Florida. The Company will initially stock its pet and human wellness products in two of Collins Tobacco and Vape’s shops as it looks to grow its retail presence in physical shops. Rene Lauritsen, Link Reservations Inc CEO commented: “We are very excited about this retail relationship with Collins Tobacco & Vape and are in discussions to stock our products in two of their locations, with the hope to add more locations for consumers to purchase our pet and human products...

Dr. Fady Hannah-Shmouni, M.D. DABIM FRCPC is a Yale University, National Institutes of Health (NIH), and University of Toronto educated medical professional with multiple board certifications in the USA and Canada. Dr. Hannah-Shmouni has extensive experience including serving as a clinician, scientist, and director in neuroendocrinology and genetics at the U.S. National Institutes of Health Dr. Hannah-Shmouni will lead Levitee’s medical affairs, clinical research, and corporate medical strategy, in addition to overseeing the domestic and international expansion of Levitee’s healthcare portfolio which includes treatment centers focused on mental health, pain and addiction Dr. Hannah-Shmouni will also spearhead Levitee’s research in psychedelic compounds for mental illnesses and pain disorders, and use his clinical and research experience...